Lucid Diagnostics Inc.

Lucid Diagnostics Inc.

Medical Devices • Healthcare • New York, NY, United States • LUCD (NCM)

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

917 813 1828 360 Madison Avenue, New York, NY 10017, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - PR Newswire
PR Newswire • Nov 12
Lucid Diagnostics Stock (LUCD) Opinions on Recent Clinical Data Release - Quiver Quantitative
Quiver Quantitative • Dec 10
Here’s Why Lucid Diagnostics (LUCD) Declined in Q3 - Yahoo Finance
Yahoo Finance • Dec 24
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
MarketBeat • Dec 14
Lucid Diagnostics: Holding Onto Medicare Coverage Hopes (NASDAQ:LUCD) - Seeking Alpha
Seeking Alpha • Sep 29

Other Medical Devices Companies

View All →
ABBOTT LABORATORIES logo Abbott Laboratories
$218.91B market cap
BOSTON SCIENTIFIC CORP logo Boston Scientific Corp.
$142.40B market cap
STRYKER CORP logo Stryker Corp.
$135.46B market cap
Medtronic plc logo Medtronic PLC
$123.80B market cap
Edwards Lifesciences Corp logo Edwards Lifesciences Corp.
$51.04B market cap
DEXCOM INC logo Dexcom Inc.
$26.50B market cap

Frequently Asked Questions

Has Lucid Diagnostics Inc. had layoffs?
No layoff events have been recorded for Lucid Diagnostics Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Lucid Diagnostics Inc. have?
Lucid Diagnostics Inc. has approximately 72 employees.
What industry is Lucid Diagnostics Inc. in?
Lucid Diagnostics Inc. operates in the Medical Devices industry, within the Healthcare sector.
Is Lucid Diagnostics Inc. a publicly traded company?
Yes, Lucid Diagnostics Inc. is publicly traded under the ticker symbol LUCD on the NCM. The company has a market capitalization of approximately $0.14 billion.
Where is Lucid Diagnostics Inc. headquartered?
Lucid Diagnostics Inc. is headquartered in New York, NY, United States at 360 Madison Avenue, New York, NY 10017, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.